About
Eye Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
1
As Collaborator
9
Total Enrollment
18,721
By Phase
NA: 9
By Status
COMPLETED: 6UNKNOWN: 3RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06977360Collaborator
Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal
NARecruiting
40 participants
Started: May 23, 2025 · Completed: Oct 31, 2025
NCT05949697Lead Sponsor
A Prospective Study of the Dry Eye Drink That Evaluates Hydration and Subject's Assessment on Eye Dryness
NACompleted
60 participants
Started: Aug 1, 2023 · Completed: May 31, 2024
NCT05074251Collaborator
Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV
NACompleted
180 participants
Started: Apr 20, 2021 · Completed: Aug 24, 2021
NCT04277299Collaborator
Intelligent Customer-driven Solution for Children and Their Parents Undergoing Day Surgery
NACompleted
40 participants
Started: Aug 12, 2020 · Completed: Feb 3, 2022
NCT04172350Collaborator
An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer Surgery
NAUnknown
112 participants
Started: Nov 19, 2019 · Completed: Oct 31, 2021
Funding History (1)
D
Jun 11, 2009
Locations (1)
Headquarters
Alpharetta, GA, United States
Map
Loading map...